BAZ1A-IN-1

Research use only, not for human use.

BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.

BAZ1A-IN-1 is a potent BAZ1A inhibitor with the KD value of 0.52 μM for the BAZ1A bromodomain. BAZ1A-IN-1 shows good anti-survival activity against cancer cell lines with high BAZ1A expression, but weak or no activity against cancer cells with low BAZ1A expression.(In Vitro):Administration of BAZ1A-IN-1 (0.015-100?μM; 96 hours) exhibits good anti-viability activity against all the four cancer cell lines that have a high expression level of BAZ1A, with IC50 values of 5.08 μM, 4.29 μM, 10.65 μM, and 7.70 μM for THP-1, ZR-75-30, BT474, and H1975 cells, respectively.

Cell Viability Assay Cell Line:THP-10 (leukemia), ZR-75-30 (breast cancer), BT474 (breast cancer), H1975 (lung cancer) cells Concentration:0.015-100 ?μM Incubation Time:96 hours Result:Significantly inhibited the viability activity in four cancer cell lines which all expressed high levels of BAZ1A.

——

——

Chromatin/Epigenetic

Epigenetic Reader Domain

——

——

——

941521-45-5

680.71

C32H24N8O6S2

>98% (HPLC)

In Vitro:?DMSO : 25 mg/mL (73.45 mM)

[O-][N+](c1cccc(NC(Nc2nc(-c3ccccc3)cs2)=O)c1)=O[O-][N+](c1cccc(NC(Nc2nc(-c3ccccc3)cs2)=O)c1)=O

——

(-20℃)

With Ice Pack

≥ 2 years